Growth Metrics

GoodRx Holdings (GDRX) Non-Current Debt (2019 - 2025)

Historic Non-Current Debt for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $484.1 million.

  • GoodRx Holdings' Non-Current Debt fell 71.35% to $484.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $484.1 million, marking a year-over-year decrease of 71.35%. This contributed to the annual value of $486.7 million for FY2024, which is 2485.58% down from last year.
  • According to the latest figures from Q3 2025, GoodRx Holdings' Non-Current Debt is $484.1 million, which was down 71.35% from $485.0 million recorded in Q2 2025.
  • In the past 5 years, GoodRx Holdings' Non-Current Debt registered a high of $658.9 million during Q1 2021, and its lowest value of $484.1 million during Q3 2025.
  • In the last 5 years, GoodRx Holdings' Non-Current Debt had a median value of $649.8 million in 2023 and averaged $608.5 million.
  • In the last 5 years, GoodRx Holdings' Non-Current Debt tumbled by 61.07% in 2021 and then tumbled by 2488.6% in 2025.
  • GoodRx Holdings' Non-Current Debt (Quarter) stood at $655.9 million in 2021, then dropped by 0.62% to $651.8 million in 2022, then fell by 0.63% to $647.7 million in 2023, then decreased by 24.86% to $486.7 million in 2024, then decreased by 0.53% to $484.1 million in 2025.
  • Its Non-Current Debt stands at $484.1 million for Q3 2025, versus $485.0 million for Q2 2025 and $485.8 million for Q1 2025.